TP53 and gastric cancer: These different models clearly show that, by combining the loss of tp53 with the loss of cdh1 and smad4 or gain of krasG12D, one can drive gastric tumorigenesis either towards a diffuse type of gastric cancer or mixed type or diffuse and intestinal.